Free Trial

Lichen China Limited (NASDAQ:LICN) Short Interest Update

Lichen China logo with Finance background

Lichen China Limited (NASDAQ:LICN - Get Free Report) was the recipient of a large increase in short interest in October. As of October 15th, there was short interest totalling 109,500 shares, an increase of 11.3% from the September 30th total of 98,400 shares. Based on an average daily volume of 195,800 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.5% of the company's stock are short sold.

Lichen China Price Performance

LICN traded up $0.01 during midday trading on Thursday, hitting $2.01. 1,804,436 shares of the company traded hands, compared to its average volume of 470,787. Lichen China has a 52 week low of $0.50 and a 52 week high of $2.44. The company's 50-day moving average is $1.88 and its 200 day moving average is $1.68.

Institutional Trading of Lichen China

A hedge fund recently bought a new stake in Lichen China stock. XTX Topco Ltd purchased a new position in Lichen China Limited (NASDAQ:LICN - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 37,315 shares of the company's stock, valued at approximately $54,000. XTX Topco Ltd owned about 0.14% of Lichen China as of its most recent SEC filing.

Lichen China Company Profile

(Get Free Report)

Lichen China Limited, together with its subsidiaries, operates as an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China and internationally. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sells teaching and learning materials.

See Also

Should you invest $1,000 in Lichen China right now?

Before you consider Lichen China, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lichen China wasn't on the list.

While Lichen China currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines